Skip to main content
v2026.1714 entries · CC-BY 4.0
CASRAI
Research Ethics & IRB Guidelines

Ethics & Informed Consent: Randomised Controlled Trial (RCT) (Ireland)

A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Randomised Controlled Trial (RCT) within the regulatory framework of Ireland.

Regionally Linked Publications606,381
Aggregated Scholarly Citations37,070,617
Tracked Infrastructure Nodes (ROR)15

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Randomised Controlled Trial (RCT) being conducted in Ireland, study designs must align with the primary regulatory legislation: EU (Clinical Trials on Medicinal Products for Human Use) Regulations 2022. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

National Ethics Board Clearance Pathway

In Ireland, health research must comply with the Irish Health Research Regulations, which require explicit consent unless a formal Consent Declaration Committee (CDC) waiver is obtained.

Administrative review and formal approval are managed by a local or regional National Research Ethics Committee (NREC). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Randomised Controlled Trial (RCT), the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: High Risk (Interventional)

This interventional trial requires strict protocol adherence, allocation concealment, robust adverse event monitoring, and emergency unblinding guidelines.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: CONSORT statement.

Special Directive: Interventional Study Protocols

Because this study design is classified as interventional, the National Research Ethics Committee (NREC) requires pre-registration of the trial on a public clinical registry (e.g. ClinicalTrials.gov or a regional WHO-compliant database) before patient enrolment begins. A detailed adverse event reporting protocol must also be submitted.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

Design-Specific Consent Focus Areas

Placebo control justification, potential side effects, adverse event monitoring, random allocation disclosure.

  • Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
  • Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
  • Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Irish Data Protection Act 2018 (Health Research Regulations).
  • Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
  • Ethics Board Contact Information: Provide the contact details of the reviewing National Research Ethics Committee (NREC) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Designing a study protocol for this Randomised Controlled Trial (RCT) in Ireland requires addressing complex ethical considerations in research for human participants. When recruiting participants in Ireland, investigators must implement strict safeguards for vulnerable populations research ethics. Prior to any intervention, subjects must sign a comprehensive research consent form outlining potential side effects and protocols. Depending on the protocol, some secondary screening phases may satisfy irb exempt research criteria to streamline approvals. Any wet-lab procedures must declare their containment ratings, keeping facilities at biosafety level 1 2 3 4 based on pathogen risk. Ethical oversight committees in Ireland audit the study's consent registry periodically to verify compliance with national legal statutes.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

RequirementNational Research Ethics Committee (NREC) StandardCONSORT statement Standard
Consent FormSigned and dated prior to study activity. Focus: Placebo control justification.Fully documented recruitment and consent paths.
Risk ManagementComprehensive risk mitigation plan. Mandates establishing an independent Data Safety Monitoring Board (DSMB) and registering the trial on a public registry (e.g., ClinicalTrials.gov).Adverse events reporting strategy.
Data RetentionCompliance with local data protection rules (EU GDPR & Irish Data Protection Act 2018 (Health Research Regulations)).Provision of open-data options where possible.

5. Academic & Research Infrastructure Matrix (Ireland)

The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Ireland mapped via the Research Organization Registry (ROR) standards-compliance framework.

Organization NameSector TypeRegistry Identification
Shellfish Ireland (Ireland)companyROR ID
Iqvia Rds Ireland LimitedcompanyROR ID
Intel (Ireland)companyROR IDWikidata/Wiki
AquaTT (Ireland)companyROR ID
CAPTEC (Ireland)companyROR ID
DiaSorin (Ireland)companyROR ID
Google (Ireland)companyROR IDWikidata/Wiki
Eolas (Ireland)companyROR ID
Greencore (Ireland)companyROR IDWikidata/Wiki
Pintail (Ireland)companyROR ID
SensL (Ireland)companyROR ID
Skytek (Ireland)companyROR ID
SolarPrint (Ireland)companyROR ID
Berand (Ireland)companyROR ID
DELL (Ireland)companyROR IDWikidata/Wiki

6. Frequently Asked Questions

How long does the review process normally take?

Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Ireland takes between 4 to 8 weeks.

Can we use digital signatures for informed consent?

Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.

Regulatory Context

CountryIreland (IE)
Ethics BoardNational Research Ethics Committee (NREC)
Primary LegislationEU (Clinical Trials on Medicinal Products for Human Use) Regulations 2022
Privacy RegulationEU GDPR & Irish Data Protection Act 2018 (Health Research Regulations)
Study DesignRandomised Controlled Trial (RCT)
Reporting StandardCONSORT statement

Verified Funding Bodies

Funder registries and DOI configurations verified for compliance in Ireland via Crossref.

  • German History SocietyID: 100012054 | Location: United Kingdom
  • Health Service ExecutiveID: 100018270 | Location: Ireland
  • Ireland FundsID: 100015023 | Location: Ireland
  • Enterprise IrelandID: 501100001588 | Location: Ireland
  • Pfizer Healthcare IrelandID: 100015278 | Location: Ireland
  • Fulbright Commission in IrelandID: 100024073 | Location: Ireland
  • Shell E and P IrelandID: 100017144 | Location: Ireland
  • Arts and Disability IrelandID: 100013461 | Location: Ireland
  • Friedreich’s Ataxia Research Alliance IrelandID: 100017897 | Location: Ireland
  • US-Ireland AllianceID: 100026750 | Location: United States

Pre-Submission Warning

Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under EU (Clinical Trials on Medicinal Products for Human Use) Regulations 2022.

Referenced across the research world

University of Cambridge logoColumbia University logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoCrossref logoUniversity of Cambridge logoColumbia University logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoCrossref logo
  • University of Cambridge logo
  • Columbia University logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo
  • Crossref logo

View CASRAI adoption →